OOG, thanks for posting that report! It has a good synopsis of some facts. As to their price target of $14 within 12 months - LOL, and I'm sure almost all here would agree! Of course, I am taking into account their assumptions of financing and partnering, but, really, the chances of this stock hitting $14 within twelve months even with non-dilutive financing and with God and the head of the FDA as partners, is no more than 1 in 20. Markey and Griifin ought to be ashamed of putting that number out there, perhaps Markey's Ph.D. should be downgraded to a "B.S." Just check out their previous targets on MNKD.

Having said all that, I sure hope what they say comes to pass!!